Trial Profile
Comparing Efficacy and safety of Dabigatran versus Uninterrupted Warfarinin Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Implantations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin (Primary)
- Indications Postoperative complications; Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2015 New trial record